{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:19:39Z","timestamp":1783639179519,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2023YFC2308402"],"award-info":[{"award-number":["2023YFC2308402"]}]},{"name":"Shanghai Pujiang Program","award":["23PJD010"],"award-info":[{"award-number":["23PJD010"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81903673"],"award-info":[{"award-number":["81903673"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-026-05150-0","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T18:08:39Z","timestamp":1779127719000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["In vitro and in vivo activity of colistin-nitroxoline combination against polymyxin heteroresistant carbapenem-resistant Klebsiella pneumoniae"],"prefix":"10.1186","volume":"26","author":[{"given":"Xin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaogang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachun","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"5150_CR1","unstructured":"World Health Organization. WHO updates list of drug-resistant bacteria most threatening to human health. WHO. 2024. https:\/\/www.who.int\/news\/item\/17-05-2024-who-updates-list-of-drug-resistant-bacteria-most-threatening-to-human-health. Accessed 12 Jul 2025."},{"key":"5150_CR2","doi-asserted-by":"publisher","first-page":"dlae052","DOI":"10.1093\/jacamr\/dlae052","volume":"6","author":"X Qin","year":"2024","unstructured":"Qin X, Ding L, Hao M, Li P, Hu F, Wang M. Antimicrobial resistance of clinical bacterial isolates in China: current status and trends. JAC Antimicrob Resist. 2024;6:dlae052.","journal-title":"JAC Antimicrob Resist"},{"key":"5150_CR3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S1473-3099(21)00399-6","volume":"22","author":"M Wang","year":"2022","unstructured":"Wang M, Earley M, Chen L, Hanson BM, Yu Y, Liu Z, et al. Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study. Lancet Infect Dis. 2022;22:401\u201312.","journal-title":"Lancet Infect Dis"},{"key":"5150_CR4","doi-asserted-by":"publisher","first-page":"e02881","DOI":"10.1128\/mBio.02881-20","volume":"12","author":"VI Band","year":"2021","unstructured":"Band VI, Satola SW, Smith RD, Hufnagel DA, Bower C, Conley AB, et al. Colistin heteroresistance is largely undetected among carbapenem-resistant Enterobacterales in the United States. mBio. 2021;12:e02881\u201320.","journal-title":"mBio"},{"key":"5150_CR5","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.cmi.2024.01.014","volume":"30","author":"Q Luo","year":"2024","unstructured":"Luo Q, Xu L, Wang Y, Fu H, Xiao T, Yu W, et al. Clinical relevance, mechanisms, and evolution of polymyxin B heteroresistance carbapenem-resistant Klebsiella pneumoniae: A genomic, retrospective cohort study. Clin Microbiol Infect. 2024;30:507\u201314.","journal-title":"Clin Microbiol Infect"},{"key":"5150_CR6","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41579-019-0218-1","volume":"17","author":"DI Andersson","year":"2019","unstructured":"Andersson DI, Nicoloff H, Hjort K. Mechanisms and clinical relevance of bacterial heteroresistance. Nat Rev Microbiol. 2019;17:479\u201396.","journal-title":"Nat Rev Microbiol"},{"key":"5150_CR7","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cmi.2022.10.018","volume":"29","author":"M Roch","year":"2023","unstructured":"Roch M, Sierra R, Andrey DO. Antibiotic heteroresistance in ESKAPE pathogens, from bench to bedside. Clin Microbiol Infect. 2023;29:320\u20135.","journal-title":"Clin Microbiol Infect"},{"key":"5150_CR8","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s00120-017-0389-1","volume":"56","author":"J Kranz","year":"2017","unstructured":"Kranz J, Schmidt S, Lebert C, Schneidewind L, Vahlensieck W, Sester U, et al. Epidemiology, diagnostics, therapy, prevention and management of uncomplicated bacterial outpatient acquired urinary tract infections in adult patients : Update 2017 of the interdisciplinary AWMF S3 guideline. Urologe A. 2017;56:746\u201358.","journal-title":"Urologe A"},{"key":"5150_CR9","first-page":"600","volume":"37","author":"P Bourlioux","year":"1989","unstructured":"Bourlioux P, Karam D, Amgar A, Perdiz M. Relation of the chelating property of nitroxoline, the surface hydrophobicity and the inhibition of bacterial adherence. Pathol Biol (Paris). 1989;37:600\u20134.","journal-title":"Pathol Biol (Paris)"},{"key":"5150_CR10","doi-asserted-by":"publisher","first-page":"107445","DOI":"10.1016\/j.ijantimicag.2025.107445","volume":"65","author":"X Chen","year":"2025","unstructured":"Chen X, Sun Z, Chen J, Xu X, Wang M, Su J. The hidden threat: Klebsiella pneumoniae may develop co-resistance to colistin and cefiderocol under pressure of colistin. Int J Antimicrob Agents. 2025;65:107445.","journal-title":"Int J Antimicrob Agents"},{"key":"5150_CR11","volume-title":"Performance standards for antimicrobial susceptibility testing 32nd ed M100","author":"Clinical and Laboratory Standards Institute","year":"2022","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing 32nd ed M100. Wayne: CLSI; 2022."},{"key":"5150_CR12","doi-asserted-by":"publisher","first-page":"6903","DOI":"10.1128\/AAC.01082-16","volume":"60","author":"M Nepka","year":"2016","unstructured":"Nepka M, Perivolioti E, Kraniotaki E, Politi L, Tsakris A, Pournaras S. In vitro bactericidal activity of trimethoprim-sulfamethoxazole alone and in combination with colistin against carbapenem-resistant Acinetobacter baumannii clinical isolates. Antimicrob Agents Chemother. 2016;60:6903\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"5150_CR13","doi-asserted-by":"publisher","first-page":"e01882","DOI":"10.1128\/AAC.01882-17","volume":"62","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Wang Q, Yin Y, Chen H, Jin L, Gu B, et al. Epidemiology of carbapenem-resistant Enterobacteriaceae infections: report from the China CRE Network. Antimicrob Agents Chemother. 2018;62:e01882\u201317.","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 2","key":"5150_CR14","doi-asserted-by":"publisher","first-page":"S196","DOI":"10.1093\/cid\/ciy660","volume":"67","author":"Q Wang","year":"2018","unstructured":"Wang Q, Wang X, Wang J, Ouyang P, Jin C, Wang R, et al. Phenotypic and genotypic characterization of carbapenem-resistant Enterobacteriaceae: data from a longitudinal large-scale CRE study in China (2012\u20132016). Clin Infect Dis. 2018;67(Suppl 2):S196\u2013205.","journal-title":"Clin Infect Dis"},{"key":"5150_CR15","doi-asserted-by":"crossref","unstructured":"Shi Y, Ru D, Wang M, Cao S, Chen D, Si Z et al. Global genomic epidemiology of carbapenemase-producing Klebsiella pneumoniae, 1996\u20132023. Int J Antimicrob Agents. 2026;67:107657.","DOI":"10.1016\/j.ijantimicag.2025.107657"},{"key":"5150_CR16","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ijantimicag.2013.12.010","volume":"43","author":"I Galani","year":"2014","unstructured":"Galani I, Orlandou K, Moraitou H, Petrikkos G, Souli M. Colistin\/daptomycin: an unconventional antimicrobial combination synergistic in vitro against multidrug-resistant Acinetobacter baumannii. Int J Antimicrob Agents. 2014;43:370\u20134.","journal-title":"Int J Antimicrob Agents"},{"key":"5150_CR17","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1128\/AAC.40.8.1914","volume":"40","author":"RL White","year":"1996","unstructured":"White RL, Burgess DS, Manduru M, Bosso JA. Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test. Antimicrob Agents Chemother. 1996;40:1914\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"5150_CR18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41564-024-01891-8","volume":"10","author":"L Daruka","year":"2025","unstructured":"Daruka L, Czikkely MS, Szili P, Farkas Z, Balogh D, Gr\u00e9zal G, et al. ESKAPE pathogens rapidly develop resistance against antibiotics in development in vitro. Nat Microbiol. 2025;10:313\u201331.","journal-title":"Nat Microbiol"},{"key":"5150_CR19","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1128\/AAC.26.4.546","volume":"26","author":"B Loh","year":"1984","unstructured":"Loh B, Grant C, Hancock RE. Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1984;26:546\u201351.","journal-title":"Antimicrob Agents Chemother"},{"key":"5150_CR20","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12866-015-0376-x","volume":"15","author":"P Stiefel","year":"2015","unstructured":"Stiefel P, Schmidt-Emrich S, Maniura-Weber K, Maniura-Weber K, Ren Q. Critical aspects of using bacterial cell viability assays with the fluorophores SYTO9 and propidium iodide. BMC Microbiol. 2015;15:36.","journal-title":"BMC Microbiol"},{"key":"5150_CR21","doi-asserted-by":"publisher","unstructured":"Sun H, Zhang Q, Wang R, Wang H, Wong YT, Wang M, Hao Q, Yan A, Kao RY, Ho PL, Li H. Resensitizing carbapenem- and colistin-resistant bacteria to antibiotics using auranofin. Nat Commun. 2020 Oct 16;11(1):5263. PMID: 33067430; PMCID: PMC7568570. https:\/\/doi.org\/10.1038\/s41467-020-18939-y.","DOI":"10.1038\/s41467-020-18939-y"},{"key":"5150_CR22","doi-asserted-by":"publisher","first-page":"e0221822","DOI":"10.1128\/spectrum.02218-22","volume":"11","author":"Y Weng","year":"2023","unstructured":"Weng Y, Wang T, Huang B, Yu H, Jia W, Shan B, et al. Multicenter study of colistin heteroresistance in carbapenem-resistant Klebsiella pneumoniae strains in China. Microbiol Spectr. 2023;11:e0221822.","journal-title":"Microbiol Spectr"},{"key":"5150_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s15010-024-02365-z","volume":"53","author":"X Wang","year":"2025","unstructured":"Wang X, Meng T, Dai Y, Ou HY, Wang M, Tang B, et al. High prevalence of polymyxin-heteroresistant carbapenem-resistant Klebsiella pneumoniae and its within-host evolution to resistance among critically ill scenarios. Infection. 2025;53:271\u201383.","journal-title":"Infection"},{"key":"5150_CR24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1128\/CMR.00058-14","volume":"28","author":"OM El-Halfawy","year":"2015","unstructured":"El-Halfawy OM, Valvano MA. Antimicrobial heteroresistance: an emerging field in need of clarity. Clin Microbiol Rev. 2015;28:191\u2013207.","journal-title":"Clin Microbiol Rev"},{"key":"5150_CR25","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1038\/s41564-019-0480-z","volume":"4","author":"VI Band","year":"2019","unstructured":"Band VI, Hufnagel DA, Jaggavarapu S, Sherman EX, Wozniak JE, Satola SW, et al. Antibiotic combinations that exploit heteroresistance to multiple drugs effectively control infection. Nat Microbiol. 2019;4:1627\u201335.","journal-title":"Nat Microbiol"},{"key":"5150_CR26","doi-asserted-by":"publisher","unstructured":"Chen X, Sun Z, Xu X, Jiang J, Su J. Genomic characterization of colistin resistance in Klebsiella spp. under the pressure of colistin. J Med Microbiol. 2023;72. https:\/\/doi.org\/10.1099\/jmm.0.001647.","DOI":"10.1099\/jmm.0.001647"},{"key":"5150_CR27","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.2147\/IDR.S311968","volume":"14","author":"J Chen","year":"2021","unstructured":"Chen J, Hu C, Wang R, Li F, Sun G, Yang M, et al. Shift in the Dominant Sequence Type of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infection from ST11 to ST15 at a Medical Center in Northeast China, 2015\u20132020. Infect Drug Resist. 2021;14:1855\u201363.","journal-title":"Infect Drug Resist"},{"key":"5150_CR28","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.3201\/eid2911.230463","volume":"29","author":"Y Wu","year":"2023","unstructured":"Wu Y, Jiang T, He X, Shao J, Wu C, Mao W, et al. Global Phylogeography and Genomic Epidemiology of Carbapenem-Resistant blaOXA-232-Carrying Klebsiella pneumoniae Sequence Type 15 Lineage. Emerg Infect Dis. 2023;29:2246\u201356.","journal-title":"Emerg Infect Dis"},{"key":"5150_CR29","doi-asserted-by":"publisher","first-page":"2569700","DOI":"10.1080\/21505594.2025.2569700","volume":"16","author":"J Chen","year":"2025","unstructured":"Chen J, Li H, Li F, Kang M, Wang R, Chu Y, et al. Iron metabolism contributes to virulence by enhancing serum resistance in the emerging high-risk clone ST15 CRKP. Virulence. 2025;16:2569700.","journal-title":"Virulence"},{"key":"5150_CR30","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.cmi.2020.03.007","volume":"26","author":"P Wistrand-Yuen","year":"2020","unstructured":"Wistrand-Yuen P, Olsson A, Skarp KP, Friberg LE, Nielsen EI, Lagerb\u00e4ck P, et al. Evaluation of polymyxin B in combination with 13 other antibiotics against carbapenemase-producing Klebsiella pneumoniae in time-lapse microscopy and time-kill experiments. Clin Microbiol Infect. 2020;26:1214\u201321.","journal-title":"Clin Microbiol Infect"},{"key":"5150_CR31","doi-asserted-by":"publisher","first-page":"106342","DOI":"10.1016\/j.ijantimicag.2021.106342","volume":"56","author":"PH Huang","year":"2021","unstructured":"Huang PH, Cheng YH, Chen WY, Juan CH, Chou SH, Wang JT, et al. Risk factors and mechanisms of in vivo emergence of colistin resistance in carbapenem-resistant Klebsiella pneumoniae. Int J Antimicrob Agents. 2021;57:106342.","journal-title":"Int J Antimicrob Agents"},{"key":"5150_CR32","doi-asserted-by":"publisher","first-page":"104419","DOI":"10.1016\/j.drudis.2025.104419","volume":"30","author":"P Papareddy","year":"2025","unstructured":"Papareddy P, Mielke SRM, Graham M, Bachmann D, Proschak E, Wichelhaus TA, et al. Rediscovering nitroxoline: a metal-chelating agent bridging infection and cancer. Drug Discov Today. 2025;30:104419.","journal-title":"Drug Discov Today"},{"key":"5150_CR33","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0378-4347(00)81056-7","volume":"222","author":"RH Sorel","year":"1981","unstructured":"Sorel RH, Snelleman C, Hulshoff A. High-performance liquid chromatographic analysis of nitroxoline in plasma and urine. J Chromatogr. 1981;222:241\u20138.","journal-title":"J Chromatogr"},{"key":"5150_CR34","doi-asserted-by":"publisher","first-page":"2294854","DOI":"10.1080\/22221751.2023.2294854","volume":"13","author":"P He","year":"2024","unstructured":"He P, Huang S, Wang R, Yang Y, Yang S, Wang Y, et al. Novel nitroxoline derivative combating resistant bacterial infections through outer membrane disruption and competitive NDM-1 inhibition. Emerg Microbes Infect. 2024;13:2294854.","journal-title":"Emerg Microbes Infect"},{"key":"5150_CR35","doi-asserted-by":"publisher","first-page":"e0106322","DOI":"10.1128\/spectrum.01063-22","volume":"10","author":"H Osei-Owusu","year":"2022","unstructured":"Osei-Owusu H, Kudera T, Strakova M, Rondevaldova J, Skrivanova E, Novy P, et al. In vitro selective combinatory effect of ciprofloxacin with nitroxoline, sanguinarine, and zinc pyrithione against diarrhea-causing and gut beneficial bacteria. Microbiol Spectr. 2022;10:e0106322.","journal-title":"Microbiol Spectr"},{"key":"5150_CR36","first-page":"594","volume":"23","author":"P He","year":"2023","unstructured":"He P, Wang Y, Wang R, Lei C, Feng M, Li X, et al. In vitro antibacterial activity of nitroxoline combined with meropenem against carbapenem-resistant bacteria and the in vivo activity in mouse urinary tract infection model. Chin J Infect Chemother. 2023;23:594\u20139.","journal-title":"Chin J Infect Chemother"},{"key":"5150_CR37","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1038\/s41467-025-58730-5","volume":"16","author":"E Cacace","year":"2025","unstructured":"Cacace E, Tietgen M, Steinhauer M, Mateus A, Schultze TG, Eckermann M, et al. Uncovering nitroxoline activity spectrum, mode of action and resistance across gram-negative bacteria. Nat Commun. 2025;16:3783.","journal-title":"Nat Commun"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-026-05150-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05150-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05150-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:12:19Z","timestamp":1783638739000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12866-026-05150-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5150"],"URL":"https:\/\/doi.org\/10.1186\/s12866-026-05150-0","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Bacterial isolates were collected under approval by the Institutional Review Board (IRB) of Huashan Hospital, Fudan University (Approval No. 2017\u2009\u2212\u2009313), in accordance with the ethical principles of the World Medical Association\u2019s Declaration of Helsinki. The requirement for informed consent was waived by the IRB of Huashan Hospital. All animal procedures were approved by the Institutional Animal Care and Use Committee (IACUC), School of Pharmacy, Fudan University (Approval No. 2025-02-HSYY-JJP-72). All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"613"}}